HBK Investments »

Ani Pharmaceuticals shares owned by HBK Investments

Quarter-by-quarter ownership of Ani Pharmaceuticals shares owned by HBK Investments from 13F filings

Historical chart of HBK Investments investment in Ani Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ani Pharmaceuticals held by HBK Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ani Pharmaceuticals by HBK Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $29M 23M 1.26

More positions owned by HBK Investments

NVIDIA Corporation Put Option (NVDA)
Cyberark Software SHS (CYBR)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
EXACT Sciences Corporation (EXAS)
Hologic (HOLX)
Norfolk Southern (NSC)
Ceridian Hcm Hldg
Confluent Class A Com (CFLT)
Chart Industries (GTLS)
Electronic Arts (EA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Comerica Incorporated
Avidity Biosciences Ord (RNA)
Warner Bros Discovery Com Ser A Call Option (WBD)
Frontier Communications Pare

View all positions for HBK Investments

Top funds holding Ani Pharmaceuticals

Camden Asset Management
Alberta Investment Management Corporation
Millennium Management
HBK Investments
Empyrean Capital Partners
Citadel Advisors
Brevan Howard Capital Management
Absolute Investment Advisers
BlackRock
Context Capital Management
Leucadia National Corporation
Point72 Asset Management
Universal- Beteiligungs- und Servicegesellschaft mbH
Gabelli Funds
Susquehanna Advisors Group

View all funds holding Ani Pharmaceuticals